Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (531-540 of 831) with videos related to

Pageof 84
Sort By:
Neuro-Oncology|June 30, 2020
Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO reviewMichael A Vogelbaum, Daria Krivosheya, Hamid Borghei-Razavi, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Neuro-Oncology|September 11, 2019
EANO guideline on the diagnosis and treatment of vestibular schwannomaRoland Goldbrunner, Michael Weller, Jean Regis, et al.
Nature Communications|November 5, 2022
Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survivalMarie Duhamel, Lauranne Drelich, Maxence Wisztorski, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2022
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101Emilie Le Rhun, Felix Boakye Oppong, Martin van den Bent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
International Journal of Cancer|February 25, 2026
Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancerJonathan Weller, Sophie Katzendobler, Frederic Thiele, et al.
Pageof 84

Showing results (531-540 of 831) with videos related to

Sort By:
Pageof 84
Neuro-Oncology|June 30, 2020
Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO reviewMichael A Vogelbaum, Daria Krivosheya, Hamid Borghei-Razavi, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Neuro-Oncology|September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastomaRadia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Neuro-Oncology|September 11, 2019
EANO guideline on the diagnosis and treatment of vestibular schwannomaRoland Goldbrunner, Michael Weller, Jean Regis, et al.
Nature Communications|November 5, 2022
Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survivalMarie Duhamel, Lauranne Drelich, Maxence Wisztorski, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2022
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101Emilie Le Rhun, Felix Boakye Oppong, Martin van den Bent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
International Journal of Cancer|February 25, 2026
Association of recurrence patterns and outcome with HR and HER2 status in patients with resected brain metastases from breast cancerJonathan Weller, Sophie Katzendobler, Frederic Thiele, et al.
Pageof 84